The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Greater Europe Investment Trust Regulatory News (BRGE)

Share Price Information for BlackRock Greater Europe Investment Trust (BRGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 627.00
Bid: 626.00
Ask: 628.00
Change: -3.00 (-0.48%)
Spread: 2.00 (0.319%)
Open: 631.00
High: 631.00
Low: 627.00
Prev. Close: 630.00
BRGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

17 Jul 2023 12:38

BlackRock Greater Europe Investment Trust Plc - Portfolio Update

BlackRock Greater Europe Investment Trust Plc - Portfolio Update

PR Newswire

LONDON, United Kingdom, July 17

The information contained in this release was correct as at 30 June 2023. Information on the Company’s up to date net asset values can be found on the London Stock Exchange website at:

 

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html. 

 

 

 

BLACKROCK GREATER EUROPE INVESTMENT TRUST PLC (LEI - 5493003R8FJ6I76ZUW55)

All information is at 30 June 2023 and unaudited.Performance at month end with net income reinvested 

 

One

Month

Three

Months

One

Year

Three

Years

Launch

(20 Sep 04)

 

 

 

 

 

 

Net asset value (undiluted)

1.5%

1.6%

26.1%

36.2%

689.7%

Share price

0.7%

1.6%

27.5%

32.5%

650.6%

FTSE World Europe ex UK

2.4%

0.6%

19.6%

32.1%

386.9%

Sources: BlackRock and Datastream 

 

At month end

Net asset value (capital only):

568.97p

Net asset value (including income):

573.66p

Share price:

539.00p

Discount to NAV (including income):

6.0%

Net gearing:

6.1%

Net yield1:

1.2%

Total assets (including income):

£579.4m

Ordinary shares in issue2:

101,000,161

Ongoing charges3:

0.98%

 

1 Based on a final dividend of 4.85p per share for the year ended 31 August 2022 and an interim dividend of 1.75p per share for the year ending 31 August 2023.

2 Excluding 16,928,777 shares held in treasury.3 The Company’s ongoing charges are calculated as a percentage of average daily net assets and using the management fee and all other operating expenses excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation, write back of prior year expenses and certain non-recurring items for the year ended 31 August 2022.

 

 

Sector Analysis

Total Assets (%)

Industrials

24.0

Technology

23.9

Consumer Discretionary

21.0

Health Care

17.2

Financials

7.3

Consumer Staples

4.4

Basic Materials

2.5

Net Current Liabilities

-0.3

 

-----

 

100.0

 

=====

 

 

 

Country Analysis

Total Assets (%)

Switzerland

19.8

France

19.4

Netherlands

19.1

Denmark

16.7

United Kingdom

6.0

Italy

5.1

Sweden

5.0

Ireland

3.6

Spain

2.5

Belgium

2.0

Germany

1.1

Net Current Liabilities

-0.3

 

-----

 

100.0

 

=====

 

 

 

 

Top 10 holdings

Country

Fund %

Novo Nordisk

Denmark

8.6

LVMH Moët Hennessy

France

7.9

ASML

Netherlands

7.1

RELX

United Kingdom

5.4

DSV Panalpina

Denmark

4.7

Lonza Group

Switzerland

4.5

Hermès International

France

4.3

STMicroelectronics

Switzerland

4.1

BE Semiconductor

Netherlands

3.6

Ferrari

Italy

3.4

 

 

Commenting on the markets, Stefan Gries, representing the Investment Manager noted:

 

During the month, the Company’s NAV rose by 1.5% and the share price by 0.7%. For reference, the FTSE World Europe ex UK Index returned 2.4% during the period. Europe ex UK markets were up during June, finishing a strong H1 with the reference index returning 9.3%.

 

During a month that lacked fundamental newsflow, markets were somewhat directionless and a number of previously ‘unloved’ sectors delivered better performance. Consumer discretionary, financials and utilities led the market, while telecommunications and health care were the bottom performers.

 

Persistent core inflation pressures meant that the European Central Bank increased rates to 3.5%, the Bank of England to 5.0%, while the Federal Reserve skipped this time. Importantly, however, the majority of hikes are behind us and in company management meetings we hear less concerns around high input costs and incremental price increases whilst the labour market, apart from many services industries, is cooling off.

 

We see pockets of weakness in the market where there have been warnings by companies exposed to destocking cycles. However, our regular contact with management teams reassures us that the direction of earnings and cashflows for the companies in our portfolio remains on track on a medium to long-term view.

 

The Company underperformed its reference index during the month, driven by negative stock selection.

 

In sector terms, the Company’s lower weight to financials was negative, as a number of banks not held performed well on the back of higher rates. An overweight allocation to the information technology sector was negative for returns as the sector saw a degree of weakness following a very strong May. The Company’s higher allocation to consumer discretionary aided returns, as did an underweight to the telecommunications sector.

 

Within health care, shares in biopharma supplier Sartorius Stedim fell post a company update. Whilst destocking of biopharma equipment, which Sartorius make, had been flagged, the magnitude of weakness surprised the market negatively. Sartorius indicated there has been little improvement to business trends during the current quarter and flagged that the destocking cycle may continue for the rest of the year.

 

This news also impacted our position in Lonza, continuing to put short-term pressure on shares. We don’t see a direct read across, suggesting the move in Lonza’s shares is sentiment driven rather than fundamental risk to their recent qualitative update confirming key projects are progressing well and that all is on track for full year targets. Also, within health care, Novo Nordisk detracted in the month despite any stock specific news.

 

Within materials, chemicals distribution business IMCD was amongst the worst performers. Whilst the company hasn’t reported yet, the sector was shaken by several chemicals companies’ profit warnings ahead of second quarter results. The sector is struggling with customer destocking given lower demand, particularly in end markets including construction, electronics and staples, as well as a sluggish recovery in China. We believe IMCD’s long-term strategy remains intact despite the potential for a weaker quarter.

 

We also saw weakness within the semiconductor sector following strong performance during the prior month on the back of Artificial Intelligence enthusiasm. Shares in BE Semi, ASML and ASMi experienced weakness which in our mind was largely due to profit taking. STMicroelectronics on the other hand – trading at lower valuations - was the strongest positive contributor during June as underlying trends such as electric vehicles appear to remain strong.

 

The Company’s only ‘auto’ stock, Ferrari – although we would classify it amongst the luxury sector – aided returns as the sportscar maker announced two new plug-in hybrid models based on the SF90 supercar. These cars will be available in a limited series at top-end prices from early 2024.

 

Our LVMH holding supported returns with shares recovering after a bit of weakness in May on China macro concerns. Our channel checks, and alternative data, continue to suggest all is on track for the company to deliver at the top of their guidance range.

 

DSV shares also continued their recent path higher with further evidence of yields staying higher for longer while the freight forwarding industry goes through a period of normalisation which appears to have stabilised, suggesting it may have found its trough.

 

Finally, not holding Siemens Energy also helped performance as the company issued a profit warning in their wind turbine business.

 

Outlook

 

The European markets continue to be unloved, recording strong outflows from the asset class. Despite this, the European equities have produced very strong performance during H1 and those gains made by the European market year-to-date are far broader than that recorded in the US, for example. This breadth, we believe, is partly conditioned by earnings surprises. With high pessimism on entry to earnings season, Q1 reporting saw the percentage of net beats exceeding 40%, the highest reading in over 15 years. In previews for Q2 earnings, we also see evidence of better bottom-up sentiment than top-down indicators portray.

 

We believe the question of ‘recession or not’ is the wrong one and looking at averages of earnings or market falls in a recession may not be useful. Ingredients for a structural recession are not present and megatrends backed by increasing capex can improve earnings outlooks. To our mind, the economic cycle cannot be understood at present without detailed bottom-up work.

 

Long-term structural trends and large amounts of fiscal spending via the Recovery Fund, Green Deal and the REPowerEU plan in Europe can drive demand for years to come, for example in areas such as infrastructure, automation, innovation in medicines, the shift to electric vehicles, digitalisation or decarbonisation. We believe the portfolio is well aligned to many of these structural spending streams. 

 

17 July 2023

 

ENDS

 

Latest information is available by typing www.blackrock.com/uk/brge on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.



Date   Source Headline
9th May 202412:06 pmPRNNet Asset Value(s)
8th May 202412:16 pmPRNNet Asset Value(s)
8th May 202410:42 amPRNDirector Declaration
7th May 202412:31 pmPRNNet Asset Value(s)
3rd May 202412:40 pmPRNDirector/PDMR Shareholding
3rd May 202412:07 pmPRNNet Asset Value(s)
2nd May 20246:15 pmPRNHalf-year Report
2nd May 202412:04 pmPRNNet Asset Value(s)
1st May 202412:02 pmPRNNet Asset Value(s)
1st May 202410:12 amPRNTotal Voting Rights
30th Apr 202412:05 pmPRNNet Asset Value(s)
29th Apr 202412:23 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 202411:40 amPRNNet Asset Value(s)
25th Apr 20245:57 pmPRNTransaction in Own Shares
25th Apr 202412:09 pmPRNNet Asset Value(s)
24th Apr 20245:12 pmPRNPortfolio Update
24th Apr 202412:09 pmPRNNet Asset Value(s)
23rd Apr 202412:10 pmPRNNet Asset Value(s)
23rd Apr 20247:00 amPRNTotal Voting Rights
22nd Apr 202411:52 amPRNNet Asset Value(s)
19th Apr 20245:35 pmPRNTransaction in Own Shares
19th Apr 202412:04 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 202412:12 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20245:47 pmPRNTransaction in Own Shares
17th Apr 202412:11 pmPRNNet Asset Value(s)
16th Apr 20245:18 pmPRNTransaction in Own Shares
16th Apr 202411:58 amPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 202411:31 amPRNNet Asset Value(s)
12th Apr 20245:41 pmPRNTransaction in Own Shares
12th Apr 202412:10 pmPRNNet Asset Value(s)
11th Apr 202412:07 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 202411:59 amPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20245:25 pmPRNTransaction in Own Shares
9th Apr 202411:41 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:56 pmPRNTransaction in Own Shares
8th Apr 202411:54 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20246:53 pmPRNTransaction in Own Shares
5th Apr 202412:12 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights
4th Apr 20245:21 pmPRNTransaction in Own Shares
4th Apr 202411:59 amPRNNet Asset Value(s)
4th Apr 20247:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.